TY - JOUR
T1 - Determining Maximal Tolerable Aerobic Training Intensity in the Acute Phase after Stroke
T2 - a Novel Dose Ranging Trial Protocol
AU - Kramer, Sharon F.
AU - Cumming, Toby
AU - Johnson, Liam
AU - Churilov, Leonid
AU - Bernhardt, Julie
N1 - Funding Information:
SK received an Australian Postgraduate Award by the Australian Government (2014-2018). Research Foundation grant. JB is supported by a NHMRC Principle Research Fellowship (#1154904). The Florey Institute of Neuroscience and Mental Health acknowledges support from the Victorian Government, in particular funding from the Operational Infrastructure Support Grant. The project has received funding from the NHMRC Centre of Research Excellence in Stroke Recovery and Brain Rehabilitation (#1077898) and the Austin Medical Research Foundation (#2-1326). Australian New Zealand Clinical Trials Registry: ACTRN12619001423101
Funding Information:
SK received an Australian Postgraduate Award by the Australian Government (2014-2018). Research Foundation grant. JB is supported by a NHMRC Principle Research Fellowship ( #1154904 ). The Florey Institute of Neuroscience and Mental Health acknowledges support from the Victorian Government , in particular funding from the Operational Infrastructure Support Grant. The project has received funding from the NHMRC Centre of Research Excellence in Stroke Recovery and Brain Rehabilitation (#1077898) and the Austin Medical Research Foundation ( #2-1326 ).
Publisher Copyright:
© 2020 Elsevier Inc.
PY - 2020/12
Y1 - 2020/12
N2 - Introduction: There is strong evidence that cardiorespiratory fitness (CRF) training improves fitness and mobility after stroke. Despite the large number of studies, the most efficacious dose is yet to be determined. Furthermore, the safety of early post-stroke training, while theoretically beneficial, remains uncertain. The aim of this study is to determine the maximum safe and tolerable intensity of CRF training early post-stroke. Methods: This is a stratified (low to moderate exercise capacity), Phase I, 5+5 dose ranging trial protocol. Participants will be recruited within one month post-stroke and stratified by their exercise-capacity (i.e. low and moderate capacity). Cohorts of five participants will perform 12 interval-based training sessions for four-weeks at a pre-determined target-intensity. The intensity will increase in each consecutive cohort, in each stratum according to pre-defined rules until the maximum safe and tolerable intensity is reached, as determined by the occurrence of dose-limiting events and occurrence of adverse events. Dose-limiting events are defined as symptoms indicative of over-training including pain and inability to perform usual activities. Study Outcome: Maximum safe and tolerable intensity of CRF training in stroke survivors with low and moderate exercise capacity. Discussion: This study is a first step in the systematic development of a CRF training intervention. We believe similar dose ranging designs may be useful for development of other rehabilitation interventions in different study populations.
AB - Introduction: There is strong evidence that cardiorespiratory fitness (CRF) training improves fitness and mobility after stroke. Despite the large number of studies, the most efficacious dose is yet to be determined. Furthermore, the safety of early post-stroke training, while theoretically beneficial, remains uncertain. The aim of this study is to determine the maximum safe and tolerable intensity of CRF training early post-stroke. Methods: This is a stratified (low to moderate exercise capacity), Phase I, 5+5 dose ranging trial protocol. Participants will be recruited within one month post-stroke and stratified by their exercise-capacity (i.e. low and moderate capacity). Cohorts of five participants will perform 12 interval-based training sessions for four-weeks at a pre-determined target-intensity. The intensity will increase in each consecutive cohort, in each stratum according to pre-defined rules until the maximum safe and tolerable intensity is reached, as determined by the occurrence of dose-limiting events and occurrence of adverse events. Dose-limiting events are defined as symptoms indicative of over-training including pain and inability to perform usual activities. Study Outcome: Maximum safe and tolerable intensity of CRF training in stroke survivors with low and moderate exercise capacity. Discussion: This study is a first step in the systematic development of a CRF training intervention. We believe similar dose ranging designs may be useful for development of other rehabilitation interventions in different study populations.
KW - Cardiorespiratory training
KW - Dose ranging
KW - Exercise
KW - Physical fitness
KW - stroke
UR - http://www.scopus.com/inward/record.url?scp=85092348369&partnerID=8YFLogxK
U2 - 10.1016/j.jstrokecerebrovasdis.2020.105359
DO - 10.1016/j.jstrokecerebrovasdis.2020.105359
M3 - Article
C2 - 33045625
AN - SCOPUS:85092348369
SN - 1052-3057
VL - 29
JO - Journal of Stroke and Cerebrovascular Diseases
JF - Journal of Stroke and Cerebrovascular Diseases
IS - 12
M1 - 105359
ER -